Duke Cancer Institute Cary

Cary, North Carolina 27518

1 studies enrolling now · 5 studies all time

What they study most

Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Gastric Neuroendocrine Carcinoma, Intestinal Neuroendocrine Carcinoma, Melanoma of Unknown Primary, Metastatic Cancer, Oligometastasis, Pancreatic Neuroendocrine Carcinoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8

Studies at this site

• Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry — Recruiting now
• Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas — Running, not enrolling
• Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial — Running, not enrolling
• Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer — Running, not enrolling
• Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth) — Withdrawn before enrolling